Healthcare provider profile · identity verified

William G Woolery, MD

Internal Medicine · SEDALIA, MO · NPI 1760477475

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Pantoprazole Sodium	Pantoprazole Sodium	298	66
Levothyroxine Sodium	Levothyroxine Sodium	281	59
Atorvastatin Calcium	Atorvastatin Calcium	271	63
Albuterol Sulfate Hfa	Albuterol Sulfate	226	60
Alprazolam	Alprazolam	217	26
Prednisone	Prednisone	214	78
Omeprazole	Omeprazole	183	47
Gabapentin	Gabapentin	144	35
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	144	24
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	143	29
Metoprolol Succinate	Metoprolol Succinate	134	30
Lisinopril	Lisinopril	133	36
Furosemide	Furosemide	128	42
Lorazepam	Lorazepam	125	15
Metformin Hcl	Metformin Hcl	124	33
Amlodipine Besylate	Amlodipine Besylate	119	30
Eliquis	Apixaban	115	24
Warfarin Sodium	Warfarin Sodium	109	20
Tramadol Hcl	Tramadol Hcl	106	25
Montelukast Sodium	Montelukast Sodium	104	21
Losartan Potassium	Losartan Potassium	102	26
Metoprolol Tartrate	Metoprolol Tartrate	89	27
Potassium Chloride	Potassium Chloride	89	25
Fluticasone Propionate	Fluticasone Propionate	86	27
Azithromycin	Azithromycin	78	53
Cefuroxime	Cefuroxime Axetil	78	50
Allopurinol	Allopurinol	77	23
Breo Ellipta	Fluticasone/Vilanterol	77	15
Simvastatin	Simvastatin	76	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	75	22
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	73	16
Hydrochlorothiazide	Hydrochlorothiazide	73	23
Amitriptyline Hcl	Amitriptyline Hcl	67	15
Ropinirole Hcl	Ropinirole Hcl	65	13
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	64	11
Spironolactone	Spironolactone	63	18
Carvedilol	Carvedilol	61	18
Glipizide	Glipizide	60	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	57	15
Meloxicam	Meloxicam	57	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	56	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	55	suppressed
Methylprednisolone	Methylprednisolone	53	39
Tamsulosin Hcl	Tamsulosin Hcl	51	18
Clonazepam	Clonazepam	50	suppressed
Citalopram Hbr	Citalopram Hydrobromide	49	14
Propranolol Hcl	Propranolol Hcl	48	14
Ventolin Hfa	Albuterol Sulfate	48	14
Symbicort	Budesonide/Formoterol Fumarate	47	12
Cephalexin	Cephalexin	45	21
Clonidine Hcl	Clonidine Hcl	44	suppressed
Donepezil Hcl	Donepezil Hcl	42	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	42	11
Nystatin	Nystatin	41	14
Rosuvastatin Calcium	Rosuvastatin Calcium	41	14
Famotidine	Famotidine	40	12
Clopidogrel	Clopidogrel Bisulfate	39	suppressed
Atenolol	Atenolol	37	12
Ozempic	Semaglutide	37	suppressed
Rexulti	Brexpiprazole	37	suppressed
Mirtazapine	Mirtazapine	35	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	33	suppressed
Methadone Hcl	Methadone Hcl	32	suppressed
Valsartan	Valsartan	32	suppressed
Memantine Hcl	Memantine Hcl	31	suppressed
Metformin Hcl Er	Metformin Hcl	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	15
Pregabalin	Pregabalin	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	19
Digoxin	Digoxin	27	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	26	suppressed
Celecoxib	Celecoxib	26	suppressed
Duloxetine Hcl	Duloxetine Hcl	25	suppressed
Levofloxacin	Levofloxacin	25	20
Lovastatin	Lovastatin	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Phenobarbital	Phenobarbital	24	suppressed
Carbamazepine Er	Carbamazepine	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	suppressed
Finasteride	Finasteride	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Irbesartan	Irbesartan	22	suppressed
Glyburide	Glyburide	21	suppressed
Sertraline Hcl	Sertraline Hcl	21	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	19	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	19	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Ofev	Nintedanib Esylate	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Divalproex Sodium	Divalproex Sodium	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Trazodone Hcl	Trazodone Hcl	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Pravastatin Sodium	Pravastatin Sodium	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	14	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Fentanyl	Fentanyl	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	12	suppressed
Roflumilast	Roflumilast	12	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	11	11
Diazepam	Diazepam	11	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	11	suppressed
Pentoxifylline	Pentoxifylline	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error